1. Home
  2. MYND vs CURX Comparison

MYND vs CURX Comparison

Compare MYND & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.57

Market Cap

28.3M

Sector

Real Estate

ML Signal

HOLD

CURX

Curanex Pharmaceuticals Inc

N/A

Current Price

$0.42

Market Cap

29.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYND
CURX
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
29.7M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
MYND
CURX
Price
$0.57
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.6K
2.7M
Earning Date
08-27-2025
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$209,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$3.61
52 Week High
$2.77
$8.60

Technical Indicators

Market Signals
Indicator
MYND
CURX
Relative Strength Index (RSI) 43.20 N/A
Support Level $0.50 N/A
Resistance Level $0.59 N/A
Average True Range (ATR) 0.06 0.00
MACD -0.00 0.00
Stochastic Oscillator 42.94 0.00

Price Performance

Historical Comparison
MYND
CURX

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

Share on Social Networks: